Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Feb 28, 2025
Product Development
Rare Disease Spotlight: A genetic seizure disorder with a growing market, pipeline
As the first Dravet syndrome products establish the market, the pipeline moves toward selective small molecules and genetic therapies
BioCentury | Nov 16, 2023
Deals
Nov. 15 Quick Takes: Kite, Arcellx expand CAR T deal
Plus: Gilde closes new €740M fund and updates from RefleXion, NMD, Lenz-Graphite, Cytovale, T-Therapeutics, Vittoria, CorMedix
BioCentury | Jun 23, 2022
Product Development
June 22 Quick Takes: Athira sags after Alzheimer’s readout
Plus Athira sags after Alzheimer’s readout, and updates from Merck, Vibe Bio and more
BioCentury | Jun 17, 2021
Emerging Company Profile
Lenz: focused on an eye drop for age-related farsightedness
Emerging Company Profile: With Versant, RA Capital-backed $47M series A, Lenz eyes pivotal study for presbyopia program
BioCentury | Feb 29, 2020
Product Development
Coming competition in myasthenia gravis
Clinical data in myasthenia gravis starts to separate which mechanisms do and don’t work
BioCentury | Mar 23, 2019
Product Development
Baby steps beyond beta amyloid
What Alzheimer’s targets beyond amyloid the biopharma industry is pursuing
BioCentury | Mar 29, 2018
Emerging Company Profile
Strengthening synapses
How Syndesi’s SV2A modulators may restore function to more synapses in AD
BioCentury | Jan 25, 2018
Strategy
Takeda rides Denali’s ATV
Denali deal reflects Takeda’s growing commitment to biologics for CNS disorders
Items per page:
1 - 10 of 370